Distinct cytokine patterns in semen influence local HIV shedding and HIV target cell activation

Journal of Infectious Diseases

Volumn 209, Issue 8, 2014, Pages 1174-1184

  Olivier, Abraham J ^a   Masson, Lindi ^a   Ronacher, Katharina ^b   Walzl, Gerhard ^b   Coetzee, David ^a   Lewis, David A ^c,d   Williamson, Anna Lise ^a,e   Passmore, Jo Ann S ^a,e   Burgers, Wendy A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

activation; cytokines; HIV; inflammation; semen; T cells

Indexed keywords

CYTOKINE; EOTAXIN; FRACTALKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEMEN ANALYSIS; SPERM; T LYMPHOCYTE ACTIVATION; VIRUS SHEDDING;

ACTIVATION; CYTOKINES; HIV; INFLAMMATION; SEMEN; T CELLS;

ADULT; CYTOKINES; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SEMEN; SOUTH AFRICA; T-LYMPHOCYTES; VIRUS SHEDDING; YOUNG ADULT;

EID: 84897374123     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit649     Document Type: Article

References (45)

1. Krieger JN, Coombs RW, Collier AC, et al. Intermittent shedding of human immunodeficiency virus in semen: Implications for sexual transmission. J Urol 1995; 154:1035-40.
2. Vernazza PL. HIV in semen: Still more to be learned. AIDS Res Ther 2005; 2:11.
3. Kokab A, Akondi MM, Sadeghi MR, et al. Raised inflammatory markers in semen from men with asymptomatic chlamydial infection. J Androl 2010; 31:114-20.
4. Gianella S, Morris SR, Anderson C, et al. Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract. AIDS 2013; 27:39-47.
5. Lisco A, Munawwar A, Introini A, et al. Semen of HIV-1-infected individuals: Local shedding of herpes viruses and reprogrammed cytokine network. J Infect Dis 2012; 205:97-105.
6. Sheth PM, Danesh A, Sheung A, et al. Disproportionately high semen shedding of HIV is associated with compartmentalized Cytomegalovirus reactivation. J Inf Dis 2006; 193:45-8.
7. Lo Caputo S, Trabattoni D, Vichi F, et al. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS 2003; 17:531-9.
8. Gianella S, Strain MC, Rought SE, et al. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J Virol 2012; 86:1307-15.
9. McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS 2006; 20:1491-5.
10. Olivier AJ, Liebenberg LJ, Coetzee D, Williamson A-L, Passmore J-AS, Burgers WA. Isolation and characterization of T cells from semen. J Immunol Methods 2012; 375:223-31.
11. Mhlongo S, Magooa P, Muller EE, et al. Etiology and STI/HIV coinfections among patients with urethral and vaginal discharge syndromes in South Africa. Sex Transm Dis 2010; 37:566-70.
12. Bebell LM, Passmore JA, Williamson C, et al. Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J Infect Dis 2008; 198:710-4.
13. Columb MO, Sagadai S. Multiple comparisons. Curr Anaes Crit Care 2006; 17:233-6.
14. Blackwell TS, Christman BW. The role of nuclear factor kappa beta in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17:3-9.
15. Kutteh WH, Mestecky J, Wira CR. Mucosal immunity in the human female reproductive tract. In: Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer L, eds. Mucosal immunology. 3rd ed, Vol 2. Oxford: Elsevier Academic Press, 2005:1631-46.
16. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cyt 2009; 29:313-26.
17. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169:1485-90.
18. Sharkey DJ, Macpherson AM, Tremellen KP, Robertson SA. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol Hum Reprod 2007; 13:491-501.
19. Politch JA, Mayer KH, Anderson DJ. Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 50:283-9.
20. Anderson JA, Ping LH, Dibben O, et al. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathogens 2010; 6:e1001053.
21. Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998; 188:1413-9.
22. Abbas AK, Lichtman AH. Cytokines. In: Abbas AK, Lichtman AH, eds. Cellular and molecular immunology. 6th ed. Philadelphia: Elsevier & Saunders, 2007:243-74.
23. Mueller YM, Katsikis PD. IL-15 in HIV infection: Pathogenic or therapeutic potential?. Eur Cyt Net 2010; 21:219-21.
24. Chahroudi A, Silvestri G. Interleukin-7 in HIV pathogenesis and therapy. Eur Cyt Net 2010; 21:202-7.
25. Sheridan WP, Hunt P, Simonet S, Ulrich TR. Hematological effects of cytokines. In: Remick DG, Friedland JS, eds. Cytokines in health and disease, 2nd ed. New York: Marcel Dekker, 1997:487-505.
26. Male D. Mechanisms of innate immunity. In: Male D, Brostoff J, Roth DBRoitt I, eds. Immunology, eds. 7th ed. Philadelphia: Mosby Elsevier, 2006:127-44.
27. Decrion AZ, Dichamp I, Varin A, Herbein G. HIV and inflammation. Curr HIV Res 2005; 3:243-59.
28. Lisco A, Introini A, Munawwar A, et al. HIV-1 imposes rigidity on blood and semen cytokine networks. Am J Reprod Immunol 2012; 68: 515-21.
29. Sheth PM, Danesh A, Shahabi K, et al. HIV-specific CD8+ lymphocytes in semen are not associated with reduced HIV shedding. J Immunol 2005; 175:4789-96.
30. Storey DF, Dolan MJ, Anderson SA, Meier PA, Walter EA. Seminal plasma RANTES levels positively correlate with seminal plasma HIV-1 RNA levels. AIDS 1999; 13:2169-71.
31. Berlier W, Bourlet T, Levy R, Lucht F, Pozzetto B, Delezay O. Amount of seminal IL-1beta positively correlates to HIV-1 load in the semen of infected patients. J Clin Virol 2006a; 36:204-7.
32. Hunt PW, Martin JN, Sinclair E, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virusinfected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-43.
33. Eggena MP, Barugahare B, Okello M, et al. T cell activation in HIVseropositive Ugandans: Differential associations with viral load, CD4+ T cell depletion, and coinfection. J Infect Dis 2005; 191:694-701.
34. Benito JM, Lopez M, Lozano S, Martinez P, Gonzalez-Lahoz J, Soriano V. CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy. AIDS Res Hum Retro 2004; 20:227-33.
35. Almeida M, Cordero M, Almeida J, Orfao A. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: A one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients. Cyt Part B Clin Cyt 2007; 72:22-33.
36. Restrepo C, Rallon NI, del Romero J, et al. Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals. J Immunol 2010; 185:982-9.
37. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59.
38. Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 6: 761-70.
39. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708-17.
40. Wu L, PaxtonWA, Kassam N, Ruffing N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-Tropic HIV-1, in vitro. J Exp Med 1997; 185:1681-91.
41. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Nat Ac Sci USA 1997; 94:1925-30.
42. Giorgi JV, Majchrowicz MA, Johnson TD, Hultin P, Matud J, Detels R. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection. AIDS 1998; 12:1833-44.
43. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: Causes and consequences. J Pathol 2008; 214:231-41.
44. Roberts AW. G-CSF: A key regulator of neutrophil production, but that's not all! Growth Factors 2005; 23:33-41.
45. Johnson LF, Coetzee DJ, Dorrington RE. Sentinel surveillance of sexually transmitted infections in South Africa: A review. Sex Trans Infect 2005; 81:287-93.